Press Releases
-
Mammoth Biosciences Secures Contract from National Institutes of Health to Scale Its High-Throughput CRISPR SARS-CoV-2 Diagnostic Platform to Address Testing Capacity Shortages
WebWireLearn More -
Mammoth Biosciences Collaborates with GSK Consumer Healthcare to Develop COVID-19 Test Using CRISPR-Based Platform
WebWireLearn More -
Mammoth Biosciences Announces Peer-Reviewed Validation Of Its Rapid, CRISPR-Based COVID-19 Diagnostic
WebWireLearn More -
Mammoth Biosciences Raises $45 Million to Build Next-Generation CRISPR Products For Therapeutics and Diagnostics
WebWireLearn More -
Mammoth Biosciences Secures Exclusive License to Commercialize Novel CRISPR Protein
WebWireLearn More -
Mammoth Biosciences Co-Founders Trevor Martin, Janice Chen, and Lucas Harrington Named to 2018 Forbes’ 30 Under 30
WebWireLearn More -
Mammoth Biosciences Raises $23 Million Led by Mayfield to Bring World’s First CRISPR-Based Disease Detection Platform To Everyday Life
WebWireLearn More -
Mammoth Biosciences Launches to Develop World’s First CRISPR-Based Detection Platform
WebWireLearn More -